Association of SAPAP3 Allelic Variants With Symptom Dimensions and Pharmacological Treatment Response in Obsessive-Compulsive Disorder
Though several SAPAP3 gene knockout studies in mice have implicated its role in compulsivity, human studies have failed to demonstrate its association with obsessive-compulsive disorder (OCD). We examined the association between allelic variants of a single nucleotide polymorphism in the SAPAP3 gene...
Gespeichert in:
Veröffentlicht in: | Experimental and clinical psychopharmacology 2022-02, Vol.30 (1), p.106-112 |
---|---|
Hauptverfasser: | , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 112 |
---|---|
container_issue | 1 |
container_start_page | 106 |
container_title | Experimental and clinical psychopharmacology |
container_volume | 30 |
creator | Naaz, Safoora Balachander, Srinivas Srinivasa Murthy, Nithyananda MS, Bhagyalakshmi Sud, Reeteka Saha, Priyanka Narayanaswamy, Janardhanan C. Reddy YC, Janardhan Jain, Sanjeev Purushottam, Meera Viswanath, Biju |
description | Though several SAPAP3 gene knockout studies in mice have implicated its role in compulsivity, human studies have failed to demonstrate its association with obsessive-compulsive disorder (OCD). We examined the association between allelic variants of a single nucleotide polymorphism in the SAPAP3 gene (rs6662980) with specific aspects of the OCD phenotype. A total of 200 individuals with OCD were genotyped using the TaqMan assay. All participants were assessed using the Mini International Neuropsychiatric Interview and the Yale-Brown Obsessive-Compulsive Scale, and their response to serotonin reuptake inhibitors (SRIs) was evaluated over naturalistic treatment and follow-up. After correcting for multiple comparisons, the G allele at rs6662980 was found to be associated with contamination and washing symptoms (p = .003). Logistic regression analysis also showed that presence of the G allele predicted poor response to SRIs (odds ratio [OR] = 2.473, 95% confidence interval [1.157, 5.407], p = .021). Interaction between presence of the G allele and the Contamination and Washing factor score predicted greater SRI resistance (OR = 3.654, [2.761, 4.547], p = .004). We conclude that specific phenotypic manifestations of OCD, which include contamination and washing-related symptoms along with resistance to SRIs, may be affected by variations in the SAPAP3 gene. Limitations of the study are the lack of a dimensional measure for assessing OCD symptoms, the evaluation of treatment response over naturalistic follow-up, and that only a single locus in the SAPAP3 gene was examined.
Public Health Significance
This study finds that a polymorphism in the SAPAP3 gene is associated with the contamination and washing symptoms of obsessive-compulsive disorder and also predicts resistance to pharmacological treatment. |
doi_str_mv | 10.1037/pha0000422 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2429770850</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2429770850</sourcerecordid><originalsourceid>FETCH-LOGICAL-a387t-e396c6c49fad621a8d0b03ac3cf584ac4063b70120d9714b72ef001e59c3977f3</originalsourceid><addsrcrecordid>eNpdkU2LFDEQhoMo7rp68QdIwIsorfnoSTrHZvyEhR3cVY9NdTrtZEl32lRamD_g7zbDrArmUnV46iFVLyFPOXvNmdRvlj2w8moh7pFzbqSqhDDyfumZqisujD4jjxBvGeO1NOIhOZNCS8Y25pz8ahGj9ZB9nGkc6XW7a3eStiG44C39CsnDnJF-83lPrw_TkuNE3_rJzVgmkMI80N0e0gQ2hvjdWwj0JjnIhcj0s8OlUI76mV716BD9T1dt47Ss4dgWE8Y0uPSYPBghoHtyVy_Il_fvbrYfq8urD5-27WUFstG5ctIoq2xtRhiU4NAMrGcSrLTjpqnB1kzJXjMu2GA0r3st3Fi2dhtjpdF6lBfkxcm7pPhjdZi7yaN1IcDs4oqdqMu1NGs2rKDP_0Nv45rm8rsj1SimlOKFenmibIqIyY3dkvwE6dBx1h3T6f6lU-Bnd8q1n9zwF_0TRwFenQBYoFvwYCFlb4NDu6ZUDnqUdbKIi1rJ31QJmn8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2428606661</pqid></control><display><type>article</type><title>Association of SAPAP3 Allelic Variants With Symptom Dimensions and Pharmacological Treatment Response in Obsessive-Compulsive Disorder</title><source>MEDLINE</source><source>EBSCOhost APA PsycARTICLES</source><creator>Naaz, Safoora ; Balachander, Srinivas ; Srinivasa Murthy, Nithyananda ; MS, Bhagyalakshmi ; Sud, Reeteka ; Saha, Priyanka ; Narayanaswamy, Janardhanan C. ; Reddy YC, Janardhan ; Jain, Sanjeev ; Purushottam, Meera ; Viswanath, Biju</creator><contributor>Stoops, William W</contributor><creatorcontrib>Naaz, Safoora ; Balachander, Srinivas ; Srinivasa Murthy, Nithyananda ; MS, Bhagyalakshmi ; Sud, Reeteka ; Saha, Priyanka ; Narayanaswamy, Janardhanan C. ; Reddy YC, Janardhan ; Jain, Sanjeev ; Purushottam, Meera ; Viswanath, Biju ; Stoops, William W</creatorcontrib><description>Though several SAPAP3 gene knockout studies in mice have implicated its role in compulsivity, human studies have failed to demonstrate its association with obsessive-compulsive disorder (OCD). We examined the association between allelic variants of a single nucleotide polymorphism in the SAPAP3 gene (rs6662980) with specific aspects of the OCD phenotype. A total of 200 individuals with OCD were genotyped using the TaqMan assay. All participants were assessed using the Mini International Neuropsychiatric Interview and the Yale-Brown Obsessive-Compulsive Scale, and their response to serotonin reuptake inhibitors (SRIs) was evaluated over naturalistic treatment and follow-up. After correcting for multiple comparisons, the G allele at rs6662980 was found to be associated with contamination and washing symptoms (p = .003). Logistic regression analysis also showed that presence of the G allele predicted poor response to SRIs (odds ratio [OR] = 2.473, 95% confidence interval [1.157, 5.407], p = .021). Interaction between presence of the G allele and the Contamination and Washing factor score predicted greater SRI resistance (OR = 3.654, [2.761, 4.547], p = .004). We conclude that specific phenotypic manifestations of OCD, which include contamination and washing-related symptoms along with resistance to SRIs, may be affected by variations in the SAPAP3 gene. Limitations of the study are the lack of a dimensional measure for assessing OCD symptoms, the evaluation of treatment response over naturalistic follow-up, and that only a single locus in the SAPAP3 gene was examined.
Public Health Significance
This study finds that a polymorphism in the SAPAP3 gene is associated with the contamination and washing symptoms of obsessive-compulsive disorder and also predicts resistance to pharmacological treatment.</description><identifier>ISSN: 1064-1297</identifier><identifier>EISSN: 1936-2293</identifier><identifier>DOI: 10.1037/pha0000422</identifier><identifier>PMID: 32730059</identifier><language>eng</language><publisher>United States: American Psychological Association</publisher><subject>Alleles ; Animals ; Drug Therapy ; Female ; Genes ; Genotype ; Human ; Male ; Mice ; Nerve Tissue Proteins - genetics ; Nucleotides ; Obsessive Compulsive Disorder ; Obsessive-Compulsive Disorder - drug therapy ; Obsessive-Compulsive Disorder - genetics ; Phenotypes ; Polymorphism ; Psychiatric Status Rating Scales ; Serotonin Reuptake Inhibitors ; Serotonin Uptake Inhibitors ; Treatment Resistant Disorders</subject><ispartof>Experimental and clinical psychopharmacology, 2022-02, Vol.30 (1), p.106-112</ispartof><rights>2020 American Psychological Association</rights><rights>2020, American Psychological Association</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a387t-e396c6c49fad621a8d0b03ac3cf584ac4063b70120d9714b72ef001e59c3977f3</citedby><orcidid>0000-0002-7317-1789 ; 0000-0001-6729-6414 ; 0000-0002-4000-268X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,778,782,27907,27908</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32730059$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Stoops, William W</contributor><creatorcontrib>Naaz, Safoora</creatorcontrib><creatorcontrib>Balachander, Srinivas</creatorcontrib><creatorcontrib>Srinivasa Murthy, Nithyananda</creatorcontrib><creatorcontrib>MS, Bhagyalakshmi</creatorcontrib><creatorcontrib>Sud, Reeteka</creatorcontrib><creatorcontrib>Saha, Priyanka</creatorcontrib><creatorcontrib>Narayanaswamy, Janardhanan C.</creatorcontrib><creatorcontrib>Reddy YC, Janardhan</creatorcontrib><creatorcontrib>Jain, Sanjeev</creatorcontrib><creatorcontrib>Purushottam, Meera</creatorcontrib><creatorcontrib>Viswanath, Biju</creatorcontrib><title>Association of SAPAP3 Allelic Variants With Symptom Dimensions and Pharmacological Treatment Response in Obsessive-Compulsive Disorder</title><title>Experimental and clinical psychopharmacology</title><addtitle>Exp Clin Psychopharmacol</addtitle><description>Though several SAPAP3 gene knockout studies in mice have implicated its role in compulsivity, human studies have failed to demonstrate its association with obsessive-compulsive disorder (OCD). We examined the association between allelic variants of a single nucleotide polymorphism in the SAPAP3 gene (rs6662980) with specific aspects of the OCD phenotype. A total of 200 individuals with OCD were genotyped using the TaqMan assay. All participants were assessed using the Mini International Neuropsychiatric Interview and the Yale-Brown Obsessive-Compulsive Scale, and their response to serotonin reuptake inhibitors (SRIs) was evaluated over naturalistic treatment and follow-up. After correcting for multiple comparisons, the G allele at rs6662980 was found to be associated with contamination and washing symptoms (p = .003). Logistic regression analysis also showed that presence of the G allele predicted poor response to SRIs (odds ratio [OR] = 2.473, 95% confidence interval [1.157, 5.407], p = .021). Interaction between presence of the G allele and the Contamination and Washing factor score predicted greater SRI resistance (OR = 3.654, [2.761, 4.547], p = .004). We conclude that specific phenotypic manifestations of OCD, which include contamination and washing-related symptoms along with resistance to SRIs, may be affected by variations in the SAPAP3 gene. Limitations of the study are the lack of a dimensional measure for assessing OCD symptoms, the evaluation of treatment response over naturalistic follow-up, and that only a single locus in the SAPAP3 gene was examined.
Public Health Significance
This study finds that a polymorphism in the SAPAP3 gene is associated with the contamination and washing symptoms of obsessive-compulsive disorder and also predicts resistance to pharmacological treatment.</description><subject>Alleles</subject><subject>Animals</subject><subject>Drug Therapy</subject><subject>Female</subject><subject>Genes</subject><subject>Genotype</subject><subject>Human</subject><subject>Male</subject><subject>Mice</subject><subject>Nerve Tissue Proteins - genetics</subject><subject>Nucleotides</subject><subject>Obsessive Compulsive Disorder</subject><subject>Obsessive-Compulsive Disorder - drug therapy</subject><subject>Obsessive-Compulsive Disorder - genetics</subject><subject>Phenotypes</subject><subject>Polymorphism</subject><subject>Psychiatric Status Rating Scales</subject><subject>Serotonin Reuptake Inhibitors</subject><subject>Serotonin Uptake Inhibitors</subject><subject>Treatment Resistant Disorders</subject><issn>1064-1297</issn><issn>1936-2293</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkU2LFDEQhoMo7rp68QdIwIsorfnoSTrHZvyEhR3cVY9NdTrtZEl32lRamD_g7zbDrArmUnV46iFVLyFPOXvNmdRvlj2w8moh7pFzbqSqhDDyfumZqisujD4jjxBvGeO1NOIhOZNCS8Y25pz8ahGj9ZB9nGkc6XW7a3eStiG44C39CsnDnJF-83lPrw_TkuNE3_rJzVgmkMI80N0e0gQ2hvjdWwj0JjnIhcj0s8OlUI76mV716BD9T1dt47Ss4dgWE8Y0uPSYPBghoHtyVy_Il_fvbrYfq8urD5-27WUFstG5ctIoq2xtRhiU4NAMrGcSrLTjpqnB1kzJXjMu2GA0r3st3Fi2dhtjpdF6lBfkxcm7pPhjdZi7yaN1IcDs4oqdqMu1NGs2rKDP_0Nv45rm8rsj1SimlOKFenmibIqIyY3dkvwE6dBx1h3T6f6lU-Bnd8q1n9zwF_0TRwFenQBYoFvwYCFlb4NDu6ZUDnqUdbKIi1rJ31QJmn8</recordid><startdate>20220201</startdate><enddate>20220201</enddate><creator>Naaz, Safoora</creator><creator>Balachander, Srinivas</creator><creator>Srinivasa Murthy, Nithyananda</creator><creator>MS, Bhagyalakshmi</creator><creator>Sud, Reeteka</creator><creator>Saha, Priyanka</creator><creator>Narayanaswamy, Janardhanan C.</creator><creator>Reddy YC, Janardhan</creator><creator>Jain, Sanjeev</creator><creator>Purushottam, Meera</creator><creator>Viswanath, Biju</creator><general>American Psychological Association</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7RZ</scope><scope>PSYQQ</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-7317-1789</orcidid><orcidid>https://orcid.org/0000-0001-6729-6414</orcidid><orcidid>https://orcid.org/0000-0002-4000-268X</orcidid></search><sort><creationdate>20220201</creationdate><title>Association of SAPAP3 Allelic Variants With Symptom Dimensions and Pharmacological Treatment Response in Obsessive-Compulsive Disorder</title><author>Naaz, Safoora ; Balachander, Srinivas ; Srinivasa Murthy, Nithyananda ; MS, Bhagyalakshmi ; Sud, Reeteka ; Saha, Priyanka ; Narayanaswamy, Janardhanan C. ; Reddy YC, Janardhan ; Jain, Sanjeev ; Purushottam, Meera ; Viswanath, Biju</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a387t-e396c6c49fad621a8d0b03ac3cf584ac4063b70120d9714b72ef001e59c3977f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Alleles</topic><topic>Animals</topic><topic>Drug Therapy</topic><topic>Female</topic><topic>Genes</topic><topic>Genotype</topic><topic>Human</topic><topic>Male</topic><topic>Mice</topic><topic>Nerve Tissue Proteins - genetics</topic><topic>Nucleotides</topic><topic>Obsessive Compulsive Disorder</topic><topic>Obsessive-Compulsive Disorder - drug therapy</topic><topic>Obsessive-Compulsive Disorder - genetics</topic><topic>Phenotypes</topic><topic>Polymorphism</topic><topic>Psychiatric Status Rating Scales</topic><topic>Serotonin Reuptake Inhibitors</topic><topic>Serotonin Uptake Inhibitors</topic><topic>Treatment Resistant Disorders</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Naaz, Safoora</creatorcontrib><creatorcontrib>Balachander, Srinivas</creatorcontrib><creatorcontrib>Srinivasa Murthy, Nithyananda</creatorcontrib><creatorcontrib>MS, Bhagyalakshmi</creatorcontrib><creatorcontrib>Sud, Reeteka</creatorcontrib><creatorcontrib>Saha, Priyanka</creatorcontrib><creatorcontrib>Narayanaswamy, Janardhanan C.</creatorcontrib><creatorcontrib>Reddy YC, Janardhan</creatorcontrib><creatorcontrib>Jain, Sanjeev</creatorcontrib><creatorcontrib>Purushottam, Meera</creatorcontrib><creatorcontrib>Viswanath, Biju</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>APA PsycArticles®</collection><collection>ProQuest One Psychology</collection><collection>MEDLINE - Academic</collection><jtitle>Experimental and clinical psychopharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Naaz, Safoora</au><au>Balachander, Srinivas</au><au>Srinivasa Murthy, Nithyananda</au><au>MS, Bhagyalakshmi</au><au>Sud, Reeteka</au><au>Saha, Priyanka</au><au>Narayanaswamy, Janardhanan C.</au><au>Reddy YC, Janardhan</au><au>Jain, Sanjeev</au><au>Purushottam, Meera</au><au>Viswanath, Biju</au><au>Stoops, William W</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Association of SAPAP3 Allelic Variants With Symptom Dimensions and Pharmacological Treatment Response in Obsessive-Compulsive Disorder</atitle><jtitle>Experimental and clinical psychopharmacology</jtitle><addtitle>Exp Clin Psychopharmacol</addtitle><date>2022-02-01</date><risdate>2022</risdate><volume>30</volume><issue>1</issue><spage>106</spage><epage>112</epage><pages>106-112</pages><issn>1064-1297</issn><eissn>1936-2293</eissn><abstract>Though several SAPAP3 gene knockout studies in mice have implicated its role in compulsivity, human studies have failed to demonstrate its association with obsessive-compulsive disorder (OCD). We examined the association between allelic variants of a single nucleotide polymorphism in the SAPAP3 gene (rs6662980) with specific aspects of the OCD phenotype. A total of 200 individuals with OCD were genotyped using the TaqMan assay. All participants were assessed using the Mini International Neuropsychiatric Interview and the Yale-Brown Obsessive-Compulsive Scale, and their response to serotonin reuptake inhibitors (SRIs) was evaluated over naturalistic treatment and follow-up. After correcting for multiple comparisons, the G allele at rs6662980 was found to be associated with contamination and washing symptoms (p = .003). Logistic regression analysis also showed that presence of the G allele predicted poor response to SRIs (odds ratio [OR] = 2.473, 95% confidence interval [1.157, 5.407], p = .021). Interaction between presence of the G allele and the Contamination and Washing factor score predicted greater SRI resistance (OR = 3.654, [2.761, 4.547], p = .004). We conclude that specific phenotypic manifestations of OCD, which include contamination and washing-related symptoms along with resistance to SRIs, may be affected by variations in the SAPAP3 gene. Limitations of the study are the lack of a dimensional measure for assessing OCD symptoms, the evaluation of treatment response over naturalistic follow-up, and that only a single locus in the SAPAP3 gene was examined.
Public Health Significance
This study finds that a polymorphism in the SAPAP3 gene is associated with the contamination and washing symptoms of obsessive-compulsive disorder and also predicts resistance to pharmacological treatment.</abstract><cop>United States</cop><pub>American Psychological Association</pub><pmid>32730059</pmid><doi>10.1037/pha0000422</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0002-7317-1789</orcidid><orcidid>https://orcid.org/0000-0001-6729-6414</orcidid><orcidid>https://orcid.org/0000-0002-4000-268X</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1064-1297 |
ispartof | Experimental and clinical psychopharmacology, 2022-02, Vol.30 (1), p.106-112 |
issn | 1064-1297 1936-2293 |
language | eng |
recordid | cdi_proquest_miscellaneous_2429770850 |
source | MEDLINE; EBSCOhost APA PsycARTICLES |
subjects | Alleles Animals Drug Therapy Female Genes Genotype Human Male Mice Nerve Tissue Proteins - genetics Nucleotides Obsessive Compulsive Disorder Obsessive-Compulsive Disorder - drug therapy Obsessive-Compulsive Disorder - genetics Phenotypes Polymorphism Psychiatric Status Rating Scales Serotonin Reuptake Inhibitors Serotonin Uptake Inhibitors Treatment Resistant Disorders |
title | Association of SAPAP3 Allelic Variants With Symptom Dimensions and Pharmacological Treatment Response in Obsessive-Compulsive Disorder |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T15%3A46%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Association%20of%20SAPAP3%20Allelic%20Variants%20With%20Symptom%20Dimensions%20and%20Pharmacological%20Treatment%20Response%20in%20Obsessive-Compulsive%20Disorder&rft.jtitle=Experimental%20and%20clinical%20psychopharmacology&rft.au=Naaz,%20Safoora&rft.date=2022-02-01&rft.volume=30&rft.issue=1&rft.spage=106&rft.epage=112&rft.pages=106-112&rft.issn=1064-1297&rft.eissn=1936-2293&rft_id=info:doi/10.1037/pha0000422&rft_dat=%3Cproquest_cross%3E2429770850%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2428606661&rft_id=info:pmid/32730059&rfr_iscdi=true |